Axinn Represented Mitchell | Genex in its Acquisition of Coventry Workers’ Comp Services
March 2, 2020
Axinn represented Mitchell | Genex, a leading provider of cost containment technology, clinical services, and disability management, in its acquisition of Coventry Workers’ Comp Services from CVS Health (NYSE: CVS). Coventry Workers’ Comp Services is a premier provider of care and cost management programs for workers' compensation and auto insurance carriers, third-party administrators, and self-insured employers. The deal, which was announced on March 2, 2020, will make Mitchell | Genex one of the country’s premier workers’ compensation and auto network providers. The deal closed on August 3, 2020. The Axinn team, which was led by partners John Harkrider and Nicholas Gaglio, and assisted by Melanie Kiser, helped to secure early termination and clearance by the DOJ.
To subscribe to our publications, click here.
Featured Insights
Featured Insights
Seven Axinn Attorneys Named to 2025 Capital Pro Bono Honor Roll
Pro Bono
Antitrust
Axinn Advises Thermo Fisher Scientific on $1.075 Billion Sale of its Microbiology Business to Astorg
Deals & Cases
Antitrust
Axinn Appoints Rachael Philbin as Chief Innovation Officer
News
Teva v. Lilly -- Clarifies Written Description of Method Claims Involving A Genus
Axinn Viewpoints
Intellectual Property
What’s Up? Competition Enforcement Updates From Italy and Portugal
Podcast
Antitrust
ACI 22nd Annual Paragraph IV Conference
Speaking Engagement
Intellectual Property
Informa 35th Annual Advanced EU London Conference
Speaking Engagement
Antitrust
Antitrust Fault Lines: Will Licensing Negotiation Groups Reshape SEP Licensing?
Byline Articles
Antitrust
AHLA Health Care Transactions Program 2026
Sponsorship
Antitrust
Kenina Lee Selected as a Member of Law360’s 2026 Competition Editorial Advisory Board
Awards & Recognitions
Antitrust

